I. Kolykhalov

发表

[Quantitative EEG correlates of the human frontal lobe dysfunction].

A. Iznak, V. Grachev, N. L. Gorbachevskaia, 2001, Vestnik Rossiiskoi akademii meditsinskikh nauk.

Some Blood Biochemistry Parameters during the Cholinergic Treatment of Alzheimer's Disease

E. Burlakova, S. Gavrilova, I. Kolykhalov, 2001, Neuroscience and Behavioral Physiology.

Prognosis of Alzheimer’s Disease Using Quantitative Mass Spectrometry of Human Blood Plasma Proteins and Machine Learning

N. Zakharova, M. Indeykina, A. Kononikhin, 2022, International Journal of Molecular Sciences.

Neuropsychiatric Symptoms and Antipsychotic Therapy in the Elderly Patients with Dementia

I. Kolykhalov, 2020, Psikhiatriya.

Frontotemporal dementia in psychiatric practice: diagnostic and therapeutic aspects

I. Kolykhalov, 2018, V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY.

A Clinical Trial of the Use of Agomelatine for the Treatment of Depression in Elderly Patients in Out-Patient Conditions

S. Gavrilova, I. Kolykhalov, N. Selezneva, 2016, Neuroscience and Behavioral Physiology.

Proteomic Markers and Early Prediction of Alzheimer’s Disease

N. Zakharova, M. Indeykina, A. Kononikhin, 2022, Biochemistry (Moscow).

Autoantibodies to β-Amyloid and Neurotransmitters in Patients with Alzheimer's Disease and Senile Dementia of the Alzheimer Type

S. Bachurin, M. Myagkova, S. Gavrilova, 2001, Bulletin of experimental biology and medicine.

Modeling fracture growth under multiple hydraulic fracturing using viscous fluid

P. A. Martynyuk, E. Sher, I. Kolykhalov, 2016, Journal of Mining Science.

Systemic Inflammatory Markers in Age-Associated Cognitive Impairment and Alzheimer’s Disease

S. Zozulya, I. Kolykhalov, T. Kliushnik, 2019, Neuroscience and Behavioral Physiology.

Studies of the Efficacy of Cereton in Mild Cognitive Impairment of the Amnestic Type Based on Testing Lipid Markers

M. Shupik, S. Gavrilova, I. Kolykhalov, 2018, Neuroscience and Behavioral Physiology.

EEG Correlates of Mild Impairments of Higher Cortical Functions

A. Iznak, A. G. Vasil'eva, S. Gavrilova, 2004, Human Physiology.

[Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia].

S. Gavrilova, I. Roshchina, I. Kolykhalov, 2011, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Content of Autoantibodies to Bradykinin and β-Amyloid1-42 as a Criterion for Biochemical Differences between Alzheimer's Dementias

M. Myagkova, S. Gavrilova, I. Kolykhalov, 2003, Bulletin of Experimental Biology and Medicine.

[Clinical and immunological effects of choline alfoscerate in the treatment of amnestic type Mild Cognitive Impairment].

S. Gavrilova, I. Kolykhalov, L. Androsova, 2022, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[Clinical efficacy and safety of choline alfoscerate in the treatment of late-onset cognitive impairment].

S. Gavrilova, I. Kolykhalov, N. Selezneva, 2018, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Therapeutic Monitoring and Prediction of the Efficacy of Neurotrophic Therapy in Patients with Amnestic-Type Mild Cognitive Decline Syndrome

O. Volpina, D. Koroev, A. Kamynina, 2019, Neuroscience and Behavioral Physiology.

[Therapeutic monitoring and prediction of the efficacy of neurotrophic treatment in patients with amnestic type of mild cognitive impairment].

O. Volpina, D. Koroev, A. Kamynina, 2017, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[The reduced level of antibodies to acetylcholine receptor alpha 7 fragment in the blood serum of patients with Alzheimer's disease].

D. Koroev, A. Kamynina, T. Volkova, 2015, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Progression of Cognitive Deficit in Older People with Mild Cognitive Impairment Treated with Cerebrolysin

I. Boksha, E. Mukaetova-Ladinska, S. Gavrilova, 2014 .

Prognosis of Progressive Cognitive Deficit in Elderly Patients with Mild Cognitive Impairment Receiving Long-Term Treatment (3-year observations)

I. Boksha, S. Gavrilova, I. Kolykhalov, 2014, Neuroscience and Behavioral Physiology.

[Prognosis of cognitive deficit progression in aged patients with mild cognitive impairment under prolonged therapy (a three year observation)].

I. Boksha, S. Gavrilova, I. Kolykhalov, 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Cholinergic Treatment of Alzheimer’s Disease and Its Influence on Health and the Quality of Life of Carers

S. Gavrilova, I. Kolykhalov, N. Gerasimov, 2011, Neuroscience and Behavioral Physiology.

Potential of Preventive Treatment of Alzheimer’s Disease: Results of a Three-Year Prospective Open Comparative Trial of the Efficacy and Safety of Courses of Treatment with Cerebrolysin and Cavinton in Elderly Patients with Mild Cognitive Impairment Syndrome

A. V. Kashin, E. Antipenko, M. Odinak, 2011, Neuroscience and Behavioral Physiology.

[Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive impairment].

A. V. Kashin, E. Antipenko, M. Odinak, 2010, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome].

S. Gavrilova, I. Kolykhalov, Ia B Fedorova, 2011, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[Detection of effective treatment of amnestic mild cognitive impairement with cereton by testing of lipids markers].

M. Shupik, S. Gavrilova, I. Kolykhalov, 2017, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Non-cognitive psychopathological symptoms in mild cognitive impairment

I. Kolykhalov, N. Cherkasov, 2021, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.

Comprehensive interdisciplinary and interdepartmental program for prevention, early detection, diagnosis and treatment of cognitive disorders in older and senile people

O. Levin, O. Tkacheva, S. Gavrilova, 2022, Russian Journal of Geriatric Medicine.

P.381 The mass spectrometry study of blood plasma proteome changes associated with Alzheimer's disease

N. Zakharova, M. Indeykina, A. Kononikhin, 2020, European Neuropsychopharmacology.

Systemic Inflammatory Markers in Age-Associated Cognitive Impairment and Alzheimer’s Disease

S. Zozulya, I. Kolykhalov, T. Kliushnik, 2019, Neuroscience and Behavioral Physiology.

[Clinical experience of the use of memantal in patients with moderate and severe Alzheimer's disease].

S. Gavrilova, I. Kolykhalov, N. Selezneva, 2016, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[Current approaches to optimize treatment of dementia and Alzheimer's disease].

I. Kolykhalov, 2016, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[ApoE genotype and efficacy of neurotrophic and cholinergic therapy in Alzheimer's disease].

G. Korovaitseva, S. Gavrilova, I. Kolykhalov, 2005, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Non-cognitive psychopathological symptoms as early manifestations of dementia: diagnostics and therapy

I. Kolykhalov, 2018, Pharmateca.

[Treatment of cognitive, behavioral and mental disorders in patients with vascular dementia: results of a multicenter, randomized, double-blind, placebo-controlled clinical trial].

A. Belova, L. Akhmadeeva, O. Tkacheva, 2023, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.